Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Alopecia areata in infants may be more common than previously thought.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

ROS may affect hair loss related to hormones.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.